T. H. Dhanya, R. Gangadhar, and N. Subha, “Clinical and economic outcomes of risperidone versus clozapine in the treatment of chronic schizophrenia”, Int J Basic Clin Pharmacol, vol. 4, no. 6, pp. 1080–1085, Jan. 2017.